Published in J Oral Pathol Med on April 01, 1998
The role of Src in solid tumors. Oncologist (2009) 1.72
Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding. Cancer Res (2009) 1.65
Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma. Clin Cancer Res (2008) 1.63
Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma. Cancer (2010) 1.15
Saracatinib Impairs Head and Neck Squamous Cell Carcinoma Invasion by Disrupting Invadopodia Function. J Cancer Sci Ther (2009) 1.11
Src family kinases and paclitaxel sensitivity. Cancer Biol Ther (2011) 1.05
Kaempferol inhibits UVB-induced COX-2 expression by suppressing Src kinase activity. Biochem Pharmacol (2010) 1.03
Phase II study of saracatinib (AZD0530) for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). Anticancer Res (2011) 1.01
Combined inhibition of PLC{gamma}-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion. Clin Cancer Res (2008) 0.92
Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistance. Oncologist (2013) 0.89
GRIM-19 mutations fail to inhibit v-Src-induced oncogenesis. Oncogene (2013) 0.77
Phosphorylated c-Src is a novel predictor for recurrence in cervical squamous cell cancer patients. Int J Clin Exp Pathol (2013) 0.76
An mRNA-specific tRNAi carrier eIF2A plays a pivotal role in cell proliferation under stress conditions: stress-resistant translation of c-Src mRNA is mediated by eIF2A. Nucleic Acids Res (2016) 0.75
Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat Cell Biol (2000) 3.49
An analysis of the interrelationship of the mixed odontogenic tumors--ameloblastic fibroma, ameloblastic fibro-odontoma, and the odontomas. Oral Surg Oral Med Oral Pathol (1981) 2.64
Malignant ameloblastoma or ameloblastic carcinoma. Oral Surg Oral Med Oral Pathol (1984) 2.51
Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res (1992) 2.00
c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol (1996) 1.75
Identification of connexin43 as a functional target for Wnt signalling. J Cell Sci (1998) 1.64
Gain-of-function mutations in the tumor suppressor gene p53. Clin Cancer Res (2000) 1.50
Myxoma of the jaws. An analysis of 15 cases. J Maxillofac Surg (1986) 1.47
Oral field cancerization: carcinogen-induced independent events or micrometastatic deposits? Cancer Epidemiol Biomarkers Prev (2000) 1.46
A case of cystic adventitial disease of the popliteal artery demonstrated by magnetic resonance imaging. J Vasc Surg (1993) 1.45
p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint. J Biol Chem (2000) 1.44
p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases. Oncogene (1998) 1.38
Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts. FEBS Lett (1998) 1.36
Increased platelet deposition on atherosclerotic coronary arteries. J Clin Invest (1994) 1.23
Positivity of the proliferation marker Ki-67 in noncycling cells. Am J Clin Pathol (1998) 1.17
Warthin's tumour and smoking. B-ENT (2005) 1.17
Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol (2006) 1.15
Osteosarcoma of the jaw bones. Analysis of 18 cases. J Maxillofac Surg (1985) 1.15
Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients. Eur J Surg Oncol (2001) 1.13
Extranodal non-Hodgkin's lymphoma of the oral tissues. An analysis of 20 cases. J Maxillofac Surg (1985) 1.13
Alpha-smooth muscle actin within epithelial islands is predictive of ameloblastic carcinoma. Oral Oncol (2009) 1.10
Grb2 overexpression in nuclei and cytoplasm of human breast cells: a histochemical and biochemical study of normal and neoplastic mammary tissue specimens. J Pathol (1997) 1.07
Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography. Ann Surg (2000) 1.07
Bio-energetic response of the heart to dopamine following brain death-related reduced myocardial workload: a phosphorus-31 magnetic resonance spectroscopy study in the cat. J Heart Lung Transplant (1999) 1.06
Glycosaminoglycans in myxoma of the jaw: a biochemical study. J Oral Pathol (1985) 1.06
Leiomyosarcomas of the oral cavity. Report of four cases and review of the literature. J Craniomaxillofac Surg (1993) 1.05
The ameloblastoma, the controversial approach to therapy. J Maxillofac Surg (1985) 1.04
Condylar hyperplasia. A clinico-pathological analysis of 22 cases. J Maxillofac Surg (1986) 1.03
Endotoxin-induced inflammation and injury of the guinea pig respiratory airways cause bronchial hyporeactivity. Am Rev Respir Dis (1988) 1.02
Chromosomal instability predicts metastatic disease in patients with insulinomas. Endocr Relat Cancer (2005) 1.02
Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue. Cancer Res (1989) 1.01
Histologic changes after vertebroplasty. J Bone Joint Surg Am (2004) 1.01
Pyruvate kinase activity and isozyme composition in normal fibrous tissue and fibroblastic proliferations. Cancer (1991) 1.00
Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates. J Biol Chem (1990) 0.99
CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kip1 expression in human peripheral T lymphocytes. Eur J Immunol (1999) 0.99
Purification and some properties of human erythrocyte hexokinase. Biochim Biophys Acta (1976) 0.99
The status of the resection margin as a prognostic factor in the treatment of head and neck carcinoma. J Craniomaxillofac Surg (1991) 0.98
Multinucleate giant cells in sublabial salivary gland tissue in Sjögren's syndrome. A diagnostic pitfall. Virchows Arch A Pathol Anat Histopathol (1984) 0.97
Verrucous hyperplasia or verrucous carcinoma. An analysis of 27 patients. J Maxillofac Surg (1983) 0.96
Glycolytic enzyme activities in breast cancer metastases. Tumour Biol (1988) 0.96
Morphometric study of histological changes in sublabial salivary glands due to aging process. J Clin Pathol (1986) 0.95
Interobserver and intraobserver variability in the histologic assessment of oral lichen planus. J Oral Pathol Med (1999) 0.95
The role of FDG PET in the clinical management of head and neck cancer. Oral Oncol (1998) 0.94
Ghost cell odontogenic carcinoma. Int J Oral Maxillofac Surg (2006) 0.94
Evaluation of the VX2 rabbit auricle carcinoma as a model for head and neck cancer in humans. J Craniomaxillofac Surg (2000) 0.94
Expression of a folate binding protein in L1210 cells grown in low folate medium. Cancer Res (1989) 0.93
Osteochondroma of the mandibular condyle. A case report. Int J Oral Maxillofac Surg (1996) 0.93
Mandibular invasion by oral squamous cell carcinoma. Clinical aspects. J Craniomaxillofac Surg (1990) 0.93
Regulation of human erythrocyte hexokinase. The influence of glycolytic intermediates and inorganic phosphate. Biochim Biophys Acta (1977) 0.92
Orbital exenteration in surgery of malignant neoplasms of the paranasal sinuses. The value of preoperative computed tomography. Arch Otolaryngol Head Neck Surg (1989) 0.92
Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems. Cancer Res (1991) 0.92
Assessment of mandibular invasion of squamous cell carcinoma by various modes of imaging: constructing a diagnostic algorithm. Int J Oral Maxillofac Surg (2008) 0.92
Non-smoking and non-drinking patients with head and neck squamous cell carcinoma: a distinct population. Oral Dis (2007) 0.91
Subunit composition, regulatory properties, and phosphorylation of phosphofructokinase from human gliomas. Cancer Res (1987) 0.91
Glycolytic enzymes in breast cancer, benign breast disease and normal breast tissue. Tumour Biol (1987) 0.91
Partial hypoxanthine-guanine phosphoribosyl transferase deficiency with full expression of the Lesch-Nyhan syndrome. Hum Genet (1981) 0.91
Activation and translocation of c-Src to the cytoskeleton by both platelet-derived growth factor and epidermal growth factor. J Biol Chem (1995) 0.90
Health risks associated with inhaled nasal toxicants. Crit Rev Toxicol (2001) 0.90
Endomyocardial biopsies after heart transplantation. The presence of immunoglobulin/immune complex deposits. Transplantation (1989) 0.89
Primary B-cell malignant lymphoma of the maxilla with a sarcomatous pattern and multilobated nuclei. Cancer (1984) 0.89
Review article. The rat incisor in toxicologic pathology. Toxicol Pathol (1996) 0.89
Acute humoral rejection after heart transplantation. Transplantation (1988) 0.89
The effect of deoxyguanosine on human lymphocyte function. I. Analysis of the interference with lymphocyte proliferation in vitro. J Immunol (1984) 0.89
Localized infantile myofibromatosis. Report of a case originating in the mandible. J Maxillofac Surg (1984) 0.88
Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance. Cancer Res (1989) 0.88
The natural course of an ossifying fibroma. A case report. Int J Oral Maxillofac Surg (1999) 0.88
Generalized hexokinase deficiency in the blood cells of a patient with nonspherocytic hemolytic anemia. Blood (1983) 0.88
A new and highly sensitive immunohistologic diagnostic criterion for Sjögren's syndrome. Arthritis Rheum (1989) 0.88
Compartmentation of hexokinase in human blood cells. Characterization of soluble and particulate enzymes. Biochim Biophys Acta (1982) 0.87
Transvenous embolisation of an arteriovenous malformation of the mandible via a femoral approach. Pediatr Radiol (1997) 0.87
The origins of multiple squamous cell carcinomas in the aerodigestive tract. Cancer (2000) 0.87
Sclerosing polycystic adenosis: a case report. B-ENT (2006) 0.87
Isozyme pattern of enolase of childhood tumors. Cancer (1984) 0.87
Neurofibromatosis presenting with a cherubism phenotype. Eur J Pediatr (2006) 0.86
Ki-67 and p53 in T2 laryngeal cancer. Laryngoscope (1998) 0.86
An image analysis study on nuclear morphology in metastasized and non-metastasized squamous cell carcinomas of the tongue. J Pathol (1998) 0.86
Characteristics of hexokinase, pyruvate kinase, and glucose-6-phosphate dehydrogenase during adult and neonatal reticulocyte maturation. Am J Hematol (1985) 0.86
Increased number of proliferating cells in oral epithelium from smokers and ex-smokers. Oral Oncol (1998) 0.86
Standardization of an enzyme-linked immunosorbent assay for the determination of protein tyrosine kinase activity. Anal Biochem (1993) 0.86
Myoepithelial carcinoma (malignant myoepithelioma): first report of an occurrence in the maxillary sinus. Histopathology (1998) 0.85
Negative growth regulation of SK-N-MC cells by bFGF defines a growth factor-sensitive point in G2. J Biol Chem (2000) 0.85
Isozymes of pyruvate kinase from human brain, meningiomas, and malignant gliomas. Cancer Res (1978) 0.85
Carcinogenic response of the nasal cavity to inhaled chemical mixtures. Mutat Res (1997) 0.85
Regional odontodysplasia in epidermal nevus syndrome. J Oral Pathol (1985) 0.85
18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer. Cancer (1999) 0.85
Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers. Lab Invest (1999) 0.84
Management of renal cell carcinoma in von Hippel-Lindau disease. Eur J Clin Invest (1999) 0.84
Multiple membrane transport systems for the uptake of folate-based thymidylate synthase inhibitors. Cancer Res (1990) 0.84
Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression. J Oral Pathol Med (1998) 0.84
Cyclin D3 regulates proliferation and apoptosis of leukemic T cell lines. J Biol Chem (1999) 0.84
[Man with cherubism]. Ned Tijdschr Geneeskd (2000) 0.84
Alkyllysophospholipid ET-18-OCH3 acts as an activator of protein kinase C in HL-60 cells. FEBS Lett (1991) 0.83
Central fibroma of the jaw, odontogenic or desmoplastic. Oral Surg Oral Med Oral Pathol (1983) 0.83
Inhibition of cell proliferation by lithium is associated with interference in cdc2 activation. FEBS Lett (1999) 0.83
Immunocytochemical demonstration of intermediate filaments in a granular cell ameloblastoma. J Oral Pathol (1984) 0.83
Characterization of some glycolytic enzymes from human retina and retinoblastoma. Cancer Res (1982) 0.83
Separation and characterization of hexokinase I subtypes from human erythrocytes. Biochim Biophys Acta (1981) 0.82
p53 overexpression in oral mucosa in relation to smoking. J Pathol (1999) 0.82